Hospital
Allegiance Hospital of Many, LLC
Allegiance Hospital of Many, LLC was paid $6.30M by Medicaid between Jan 2018 and Dec 2024, across 97 billing codes. Its largest line is 99284, emergency room visit (serious) — 37% of everything it billed.
33Billing provider infoALLEGIANCE HOSPITAL OF MANY, LLC
MANY, LA 71449
MANY, LA 71449
33aNPI1568626273assigned 07/11/2008
33bProvider typeMedicare Defined Swing Bed Hospital Unit
28Total paid$6.30M
24GClaims151,870
24DCodes billed97
24AFirst – last monthJan 2018 – Dec 2024
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 14,953 | $539K | |
| 2019 | 14,498 | $568K | |
| 2020 | 14,154 | $463K | |
| 2021 | 19,717 | $958K | |
| 2022 | 31,713 | $967K | |
| 2023 | 35,751 | $1.46M | |
| 2024incomplete | 21,084 | $1.34M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 37% | 9,342 | 8,461 | $2.35M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 18% | 3,489 | 3,072 | $1.12M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 17% | 6,708 | 6,208 | $1.08M |
| 80053 | Comprehensive metabolic panel | 2.6% | 21,322 | 18,537 | $162K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 2.3% | 3,227 | 2,855 | $146K |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 2.2% | 370 | 347 | $141K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 2.1% | 23,050 | 20,019 | $131K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 1.9% | 485 | 374 | $121K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 1.7% | 3,412 | 3,050 | $106K |
| 70450 | Computed tomography, head or brain; without contrast material | 1.3% | 375 | 333 | $83K |
| 71045 | Radiologic examination, chest; single view | 1.2% | 2,520 | 2,256 | $77K |
| 94760 | 1.0% | 7,922 | 6,261 | $66K |
85 more codes
| 96375 | Therapeutic injection; each additional sequential IV push | 1.0% | 2,033 | $66K |
| 36415 | Collection of venous blood by venipuncture | <1% | 20,222 | $46K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 85 | $44K |
| G0378 | Hospital observation service, per hour | <1% | 135 | $43K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 678 | $41K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 796 | $33K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 1,014 | $33K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 1,207 | $31K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 2,213 | $30K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 1,840 | $24K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 1,160 | $23K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 228 | $22K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 1,650 | $22K |
| 80061 | Lipid panel | <1% | 1,735 | $18K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 2,393 | $17K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 1,032 | $16K |
| 84484 | <1% | 2,385 | $16K | |
| 86710 | <1% | 1,137 | $16K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 2,190 | $15K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 439 | $14K |
| 82607 | <1% | 915 | $11K | |
| 81000 | <1% | 3,809 | $9K | |
| 82746 | <1% | 727 | $8K | |
| 82728 | <1% | 734 | $7K | |
| 82550 | <1% | 1,823 | $7K | |
| 84439 | <1% | 982 | $7K | |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 122 | $7K |
| 82553 | <1% | 1,055 | $6K | |
| 83735 | <1% | 1,379 | $6K | |
| 83550 | <1% | 761 | $5K | |
| 81003 | <1% | 3,589 | $5K | |
| 83540 | <1% | 782 | $4K | |
| 93880 | <1% | 14 | $3K | |
| 86376 | <1% | 284 | $3K | |
| 93925 | <1% | 15 | $3K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 443 | $3K |
| 87081 | <1% | 436 | $3K | |
| 83880 | <1% | 138 | $3K | |
| 81025 | <1% | 372 | $3K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 48 | $3K |
| 74018 | <1% | 39 | $2K | |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | <1% | 33 | $2K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 282 | $2K |
| 81002 | <1% | 726 | $2K | |
| 86803 | <1% | 172 | $2K | |
| 80050 | General health panel | <1% | 49 | $2K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 192 | $2K |
| 84703 | <1% | 205 | $2K | |
| J0780 | Injection, prochlorperazine, up to 10 mg | <1% | 66 | $1K |
| 82784 | <1% | 506 | $1K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 229 | $1K |
| 93041 | <1% | 111 | $1K | |
| 96376 | <1% | 58 | $927.72 | |
| 82785 | <1% | 293 | $821.42 | |
| 36591 | <1% | 802 | $802.49 | |
| 73630 | <1% | 17 | $786.71 | |
| 80305 | <1% | 72 | $775.74 | |
| 83690 | <1% | 336 | $757.74 | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 113 | $728.31 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 33 | $693.49 |
| 84481 | <1% | 69 | $633.98 | |
| 72100 | <1% | 13 | $560.80 | |
| 87807 | <1% | 36 | $458.50 | |
| 82043 | <1% | 117 | $452.58 | |
| 86140 | <1% | 189 | $425.28 | |
| 87420 | <1% | 30 | $416.82 | |
| 86592 | <1% | 115 | $380.03 | |
| 82150 | <1% | 291 | $363.97 | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 28 | $222.35 |
| J2704 | Injection, propofol, 10 mg | <1% | 503 | $193.27 |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 13 | $191.56 |
| 83516 | <1% | 67 | $148.77 | |
| J2175 | Injection, meperidine hydrochloride, per 100 mg | <1% | 121 | $146.14 |
| 85651 | <1% | 42 | $144.99 | |
| 85730 | <1% | 26 | $138.23 | |
| 86677 | <1% | 184 | $130.27 | |
| 86038 | <1% | 13 | $108.81 | |
| 85610 | <1% | 37 | $108.56 | |
| 85379 | <1% | 19 | $91.62 | |
| 84480 | <1% | 13 | $89.04 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 15 | $54.72 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 268 | $15.52 |
| 87338 | <1% | 51 | $6.52 | |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | <1% | 18 | $3.90 |
| 00000 | 0% | 36 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialBYLES, DEBRA (CEO)